Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10767026 | Biochemical and Biophysical Research Communications | 2007 | 4 Pages |
Abstract
To evaluate folate-dependent carbon incorporation into the purine ring, we measured 13C-enrichment independently at C2 and C8 of urinary uric acid (the final catabolite of purines) in a healthy male after an independent oral dose of [6RS]-5-[13C]-formyltetrahydrofolate ([6RS]-5-H13CO-H4folate) or 10-H13CO-7,8-dihydrofolate (10-H13CO-H2folate). The C2 position was 13C-enriched more than C8 after [6RS]-5-H13CO-H4folate, and C2 was exclusively enriched after 10-H13CO-H2folate. The enrichment of C2 was greater from [6RS]-5-H13CO-H4folate than 10-H13CO-H2folate using equimolar bioactive doses. Our data suggest that formyl C of [6RS]-10-H13CO-H4folate was not equally utilized by glycinamide ribotide transformylase (enriches C8) and aminoimidazolecarboxamide ribotide (AICAR) transformylase (enriches C2), and the formyl C of 10-H13CO-H2folate was exclusively used by AICAR transformylase. 10-HCO-H2folate may function in vivo as the predominant substrate for AICAR transformylase in humans.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Joseph E. Baggott, Gregory S. Gorman, Sarah L. Morgan, Tsunenobu Tamura,